It is not always easy to diagnose tuberculosis (TB) accurately; thus, there are always continuous trials to find the best possible method with a short duration and acceptable accuracy. This study aimed to correlate between serum adenosine deaminase (ADA) and cancer antigen 125 (CA125) in the assessment of severity of pulmonary TB.
Background
To diagnose pulmonary tuberculosis (TB), we can depend on clinical symptoms, chest radiography, presence of Mycobacterium tuberculosis in sputum smear microscopy, and culture [1] .
However, in certain circumstances, when sputum samples are free from acid-fast bacilli or respiratory specimens may not be available, other methods have to be used to diagnose TB [2] .
Cancer antigen 125 (CA125) is a large molecularweight glycoprotein originating from the celomic epithelium. CA125 is released from mesothelial cell lines and bronchial epithelial cells if activated by
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High levels of CA125 have been recorded in patients with pulmonary and extrapulmonary TB [4] .
Adenosine deaminase (also known as adenosine aminohydrolase or ADA) is an enzyme involved in purine metabolism. It plays a great role in development and maintenance of the immune system, but the full physiological role of ADA is not yet fully studied [5] .
There are two types of ADA: ADA1 and ADA2. Both regulate the ratio of adenosine to deoxyadenosine potentiating the killing of parasites. ADA2 presents in the human plasma and serum and exists solely as a homodimer [6] .
ADA2 is increased in many diseases such as rheumatoid arthritis, psoriasis, and sarcoidosis and in multiple cancers [7] . High-performance liquid chromatography or enzymatic or calorimetric techniques can be used to measure the total plasma ADA [8] .
ADA is a biomarker reported to have the ability to be used as a diagnostic tool in TB [9] . It plays a great role in differentiation between tuberculous and nontuberculous pleural effusion [10] .
There is limited available literature studying the use of serum ADA in activity of the disease and follow-up after recovery [11] .
The purpose of the present study is to correlate between serum ADA and CA125 levels in assessment of severity of pulmonary TB.
Patients and methods
This prospective randomized study was conducted on 45 adult patients with active pulmonary TB admitted to Abbassia Chest Hospital during the period from January 2016 to April 2017.
The patients were classified into three groups:
( [13] ; sputum culture on L-J media; and CA125 and ADA analysis, where 5 ml of blood was collected in a disposable syringe under complete aseptic conditions and centrifuged and serum separated, from which CA125 and ADA were measured using CA125II kits and ADA016 kits, respectively.
Patients received antituberculous treatment in the hospital according to WHO and national guidelines [14] .
This study took approval of the local ethical committee of scientific research.
Statistical analysis
The collected data were coded, tabulated, and statistically analyzed using statistical package for the social sciences, version 23 IBM SPSS statistics (v.23, IBM Corp., USA). Independent t test and χ 2 test were used for independent variables.
The level of significance was determined in terms of P value, where P value less than 0.050 is significant, otherwise nonsignificant.
Results
The three groups were matched for age and sex. The age of patients ranged from 20 to 50 years. The mean age of the patients was 27.800±0.5.809, 32.267±7.096, and 27.800 ±5.809 in the groups I, II, and III, respectively. In group I, 11 were males and four were females, whereas multidrug resistance TB (group II) had 10 males and five females. Among the patients whose sputum results converted to negative (group III), there were 11 males and four females.
There was an insignificant statistical difference in both serum CA125 and serum ADA regarding age and sex.
A statistical significant difference was reported among the studied groups in serum CA125 and serum ADA, where P values were 0.018 and 0.014, respectively. Both were the highest in group I and lower in group III after receiving treatment for 2 months (Tables 1 and 2 ).
Approximately 77% of the cases were sputum positive and 33% were sputum negative. One-third of cases had drugresistant TB, 86% of them were rifampicin resistant, 6% were Isoniazide (INH) resistant, and 6% were resistant to rifampicin, INH, and streptomycin. Serum ADA was significantly higher in sputum positive cases than negative ones (Table 4) , but there was an insignificant statistical difference in serum CA125 between positive and negative cases ( Table 5 ). There was an insignificant statistical difference between types of drug resistance regarding serum ADA and serum CA125 (Tables 3 and 4 ).
In the studied cases, moderate advanced lesion (46%) was the most frequent followed by minimal lesion (40%) and far advanced one (13%). Serum CA125 and serum ADA were higher in far advanced disease than moderate advanced and minimal disease (Tables 3  and 4 ).
In the current study, there was a statistically significant difference between the studied groups regarding ESR, where P value was less than 0.001 (Table 1) , and there was a significant positive correlation between serum ADA and serum CA125 and ESR (Tables 3 and 4 ).
There was an insignificant statistical correlation between both serum ADA and CA125 (P=0.091) ( Table 5 ).
Discussion
It was reported that patients with pulmonary and extrapulmonary TB had higher levels of serum CA125 than normal patients; thus, measuring the serum CA125 level may be useful to discriminate between active and inactive diseases [15] .
Moreover, some studies revealed high levels of ADA in serum and bronchoalveolar lavage of patients with pulmonary TB [16] .
This study was planned to correlate between serum ADA and CA125 levels in assessment of severity of pulmonary TB. 110.201 P 0 <0.001* P 1 <0.001* P 2 <0.001* P 3 <0.001* ADA, adenosine deaminase; ANOVA, analysis of variance; CA125, cancer antigen 125; ESR, erythrocyte sedimentation rate. P 0 , difference among three groups. P 1 , difference between groups I and II. P 2 , difference between groups I and III. P 3 , difference between groups II and III. *P value < 0.050 is significant, otherwise is non significant. In the present study, there was a significant statistical difference among the three studied groups regarding serum CA125, where it was significant higher in group I (mean value, 64.427±65.2 U/ml) than group II and group III, but there was no statistical significant difference in serum CA125 between types of drug resistance in group II. The results of this study were similar to Yilmaz et al. [21] , Said et al. [19] , and Kim et al. (2013) [22] .
In this study, the serum level of CA125 was higher in group I than group II. This result was in contrary to Rizk et al. [23] who found that serum level of CA125 was higher in resistant strain than sensitive strain. This difference may be owing to that patients with drugresistant pulmonary TB were on antituberculous treatment for more than 6 months.
In the present study, the serum CA125 was lower in group III than group I after receiving antituberculous treatment for 2 months, and there was sputum result conversion which decreased to 27.22±26.95 U/ml. Sabin and Yildiz [24] found the same result as the pretreatment levels of serum CA125 of 76.48±24.71 U/ ml were higher than posttreatment levels (mean=22.78 ±8.02 U/ml).
In the current study, there was a significant statistical difference regarding chest radiography among the studied groups, with P value=0.028, and there was a significant positive correlation between chest radiography and serum level of CA125 as it was significantly higher in far advanced and moderate advanced disease than minimal lesion ones.
Kim et al. [25] reported similar results and concluded that we can take CA125 as one of the parameters in the assessment of severity of TB.
In this study, there was a significant statistical difference among the three groups in sputum ZN, where P value was less than 0.001, but there was insignificant statistical difference in serum CA125 levels in three studied groups regarding the results of sputum analysis for acid fast bacilli (AFB).
This was in contrast with Mohammad et al. [3] who showed that there was a statistically significant difference in serum CA125 levels in patients with newly diagnosed pulmonary TB regarding the results of sputum analysis for AFB. Kim et al. [22] found that CA125 was higher in sputum positive cases than negative ones. This difference may be explained by different criteria of selected cases.
In the current study, there was a statistically significant difference in ESR among the studied groups, where P value was less than 0.001, as it was higher in group I than group II and group III, and there was a significant positive correlation between ESR and serum CA125, with P value=0.030.
This result was in accordance with Mohammad et al. [3] who reported that ESR was significantly higher in patients with TB than patients with other pulmonary infections.
Simultaneously, in the current study, there was a significant statistical difference between group I, group II, and group III regarding serum ADA, where it was higher in group I (mean±SD, 64.427 ±65.204 IU/l) than group II (mean±SD, 24.033 ±0.11.947 IU/l) and group III (mean±SD, 27.220 ±26.954 IU/l). However, no statistical significant difference was found in serum ADA between types of drug resistance in group II.
This result was in accordance with Afrasiabian et al. [9] who found that patients with pulmonary TB had higher levels of serum ADA than non-TB patients.
In the study by Dinnes et al. [26] , significant differences in serum ADA levels between patients with TB and patients with other chest infections have not been demonstrated.
In this study, the serum ADA was lower in posttreatment group (group II) and after sputum conversion (group III) than active pretreatment cases (group I). This was in agreement with Saini et al. [27] who found that there was significant statistically significant difference in serum ADA before and after 2 months of treatment, with P value less than 0.00.
In this study, the serum level of ADA recorded higher levels in patients with far advanced and moderate advanced lesions than those with minimal ones.
This result was in accordance with Varma and Toppo [20] who found that serum ADA higher in fibrocavitary TB than infiltrative and consolidative lesions.
In this study, there was a statistical significant difference in serum ADA levels among the studied groups regarding the results of sputum analysis for AFB where serum ADA was higher in sputum positive cases than sputum negative ones.
Varma and Toppo [20] support our result and found that mean serum ADA levels in sputum positive cases were higher than negative cases.
On the contrary, Saini et al. [27] reported that the serum ADA was higher in sputum negative than positive cases.
In the current study, there was a significant positive correlation between serum ADA and ESR, with P value=0.006. Takashi et al. [28] support our result and observed that there was a significant positive correlation between serum ADA activity and ESR at 1 h, where r=0.56.
Finally, there was an insignificant statistical correlation between serum ADA and serum CA125 in the studied groups (P=0.091). El Hoshy et al. [29] who compared CA125 and ADA in tuberculous plueral effusion reported that CA125 more specific than ADA in diagnosis of tuberculous pleural effusion but ADA more sensitive.
Unfortunately, there were some limitation in our study, such as the sample size was small and the correlation between both markers and duration of treatment was not studied.
Conclusion
From the present study, we concluded that both serum CA125 and serum ADA can be used in follow-up, assessment of severity of the disease, and monitoring the response to treatment, but they had no role in determination of bacteriological load of the disease, and there was insignificant statistical correlation between serum ADA and CA125.
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